PET/CT in patients with hepatocellular carcinoma using [18F]fluorocholine: preliminary comparison with [18F]FDG PET/CT
暂无分享,去创建一个
Khaldoun Kerrou | Jean-Noël Talbot | J. Talbot | F. Montravers | L. Fartoux | O. Rosmorduc | Laetitia Fartoux | Olivier Rosmorduc | N. Ganne | Françoise Montravers | R. Poupon | Fabrice Gutman | Jean-Didier Grange | Nathalie Ganne | Dany Grahek | Raoul Poupon | F. Gutman | K. Kerrou | D. Grahek | J. Grangé
[1] Chi-Lai Ho,et al. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] V. Mazzaferro,et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.
[3] M J Welch,et al. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. , 2001, Nuclear medicine and biology.
[4] R. Coleman,et al. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. , 2001, Cancer research.
[5] M P Sandler,et al. Evaluation of benign vs malignant hepatic lesions with positron emission tomography. , 1998, Archives of surgery.
[6] H D Humes,et al. Carbon-11-acetate PET imaging in renal disease. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] J. Bruix,et al. Management of hepatocellular carcinoma , 2005, Hepatology.
[8] M. Coel,et al. Prostate cancer localization with 18fluorine fluorocholine positron emission tomography. , 2005, The Journal of urology.
[9] S. Zeuzem,et al. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma , 1999, American Journal of Gastroenterology.
[10] G. V. von Schulthess,et al. Fluorocholine PET/CT in patients with prostate cancer: initial experience. , 2005, Radiology.
[11] J. Ruíz-Cabello,et al. Phospholipid metabolites as indicators of cancer cell function , 1992, NMR in biomedicine.
[12] M. Ozaki,et al. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] M. Laeeq Khan,et al. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. , 2000, Journal of hepatology.
[14] C. Zornig,et al. Impact of Staging on the Treatment of Hepatocellular Carcinoma , 1993, Endoscopy.
[15] T. Hara. 18F-fluorocholine: a new oncologic PET tracer. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] P. Shreve,et al. Imaging of the pancreas and related diseases with PET carbon-11-acetate. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] G. Liu,et al. Quantification of choline compounds in human hepatic tumors by proton MR spectroscopy at 3 T , 2005, Magnetic resonance in medicine.